Список литературы

1. Азимова Ю.Э., Амелин А.В., Алферова В.В., Артеменко А.Р., Ахмадеева Л.Р., Головачева В.А., Данилов А.Б., Екушева Е.В., Исагулян Э.Д., Корешкина М.И., Курушина О.В., Латышева Н.В., Лебедева Е.Р., Наприенко М.В., Осипова В.В., Павлов Н.А., Парфенов В.А., Рачин А.П., Сергеев А.В., Скоробогатых К.В., Табеева Г.Р., Филатова Е.Г. Клинические рекомендации "Мигрень". Журнал неврологии и психиатрии им. С.С. Корсакова. 2022; 122(1-3): 4 - 36.

2. Kelman L. The triggers or precipitants of the acute migraine attack. Cephalalgia. 2007; 27(5): 394 - 402 doi: 10.1111/j.1468-2982.2007.01303.x

3. Goadsby, P.J. Migraine-current understanding and treatment/P.J. Goadsby, R.B. Lipton, M.D. Ferrari//N. Engl. J. Med. - 2002. - Vol. 346 (4). - P. 257 - 270.

4. Aurora, S.K. Spectrum of illness: understanding biological patterns and relationships in chronic migraine/S.K. Aurora//Neurology. - 2009. - Vol. 72, Suppl. 5. - P. 8 - 13.

5. Hershey AD. Pediatric headache: update on recent research. Headache: The Journal of Head and Face Pain. 2012; 52(2): 327 - 332. https://doi.org/10.1111/j.1526-4610.2011.02085.x

6. Silberstein, S.D. Practice parameter: evidence-based guidelines for migraine headache (an evidence-based review): report of the Quality Standards Subcommittee of the American Academy of Neurology/S.D. Silberstein//Neurology. - 2000. - Vol. 55. - P. 754 - 762.

7. Welch, K.M. Periaqueductal gray matter dysfunction in migraine: cause or the burden of illness?/K.M. Welch, V. Nagesh, S.K. Aurora, N. Gelman//Headache. - 2001. - Vol. 41 (7). - P. 6629 - 37.

8. Dodick, D. Central sensitization theory of migraine: clinical implications/D. Dodick, S. Silberstein//Headache. - 2006. - Vol. 46, Suppl. 4. - P. 182 - 191.

9. Burstein, R. An association between migraine and cutaneous allodynia/R. Burstein, D. Yarnitsky, I. Goor-Aryeh [et al.]//Ann. Neurol. - 2000. - Vol. 47 (5). - P. 614 - 624.

10. Burstein, R. Managing migraine associated with sensitization/R. Burstein, M. Jakubowski//Handb. Clin. Neurol. - 2010. - Vol. 97. - P. 207 - 15.

11. Ashkenazi, A. Identifying cutaneous allodynia in chronic migraine using a practical clinical method/A. Ashkenazi, M. Sholtzow, J.W. Shaw [et al.]//Cephalalgia. - 2007. - Vol. 27 (2). - P. 111 - 7.

12. Bigal, M.E. When migraine progresses: transformed or chronic migraine/M.E. Bigal, R.B. Lipton//Expert Rev. Neurother. - 2006. - N 6 (3). - P. 297 - 306.

13. Lovati, C. Allodynia in different forms of migraine/C. Lovati, D. D'Amico, S. Rosa [et al.]//Neurol. Sci. - 2007. - Vol. 28. - P. 220 - 221.

14. Vahlquist, B. Migraine of early onset. A study of thirty one cases in which the disease first appeared between one and four years of age/B. Vahlquist, G. Hackzell//ActaPaediatr. - 1949. - Vol. 38. - P. 622 - 636.

15. Mortimer, M.J. Epidemiology of headache and childhood migraine in an urban general practice using Ad Hoc, Vahlquist and IHS criteria/M.J. Mortimer, J. Kay, A. Jaron//Dev. Med. ChildNeurol. - 1992. - Vol. 34 (12). - P. 1095 - 1101.

16. Bille, B.S. Migraine in school children. A study of the incidence and short-term prognosis, and a clinical, psychological and electroencephalographic comparison between children with migraine and matched controls/B.S. Bille//ActaPaediatr. Suppl. - 1962. - Vol. 136. - P. 1 - 151.

17. Sillan, M. Prevalence of migraine and other headache in Finnish children starting school/M. //Headache. - 1976. - Vol. 15 (4). - P. 288 - 290.

18. Abu-Arafeh, L. Prevalence of headache and migraine in school children/L. Abu-Arafeh, G. Russell//British Medical Journal. - 1994. - Vol. 309. - P. 765 - 769.

19. Barea, L.M. An epidemiologic study of headache among children and adolescents of southern Brazil/L.M. Barea, M. Tannhauser, N.T. Rotta//Cephalalgia. - 1996. - Vol. 16(8). - P. 545 - 549.

20. Lu, S.R. Migraine prevalence in adolescents aged 13 - 15: a student population-based study in Taiwan/S.R. Lu, J.L. Fuh, K.D. Juang, S.J. Wang//Cephalalgia. - 2000. - Vol. 20 (5). - P. 479 - 485.

21. Zwart, J.A. The prevalence of migraine and tension-type headaches among adolescents in Norway. The Nord-Trmndelag Health Study (Head-HUNT-Youth), a large population-based epidemiological study/J.A. Zwart, G. Dyb, T.L. Holmen [et al.]//Cephalalgia. - 2004. - Vol. 24 (5). - P. 373 - 379.

22. Split, W. Epidemiology of migraine among students from randomly selected secondary schools in Lodz/W. Split, W. Neuman//Headache. - 1999. - Vol. 39(7). - P. 494 - 501.

23. Karli, N. Headache prevalence in adolescents aged 12 to 17: a student-based epidemiological study in Bursa/N. Karli, N. Akis, M. Zarifoplu [et al.]//Headache. - 2006. - Vol. 46 (4). - P. 649 - 655.

24. Табеева Г.Р. Головные боли в общеврачебной практике. Терапевтический архив. 2022. Т. 94. N 1. С. 114 - 121.

25. Осипова В.В., Филатова Е.Г., Артеменко А.Р. с соавт. Диагностика и лечение мигрени: рекомендации российских экспертов. Журнал неврологии и психиатрии им. С.С. Корсакова 2017; 2: 28 - 42.

26. Mitsikostas D., Ashina M., Craven A. et al. EHF committee. European headache federation consensus on technical investigation for primary headache disorders. J. Headache Pain. 2015; 17: 5.

27. Осипова В.В., Филатова Е.Г., Артеменко А.Р., Лебедева Е.Р., Азимова Ю.Э., Латышева Н.В., Сергеев А.В., Амелин А.В., Корешкина М.И., Скоробогатых К.В., Екушева Е.В., Наприенко М.В., Исагулян Э.Д., Рачин А.П., Данилов А.Б., Курушина О.В., Парфенов В.А., Табеева Г.Р., Гехт А.Б., Яхно Н.Н. и др. Краткие рекомендации российских экспертов по диагностике и лечению мигрени. РМЖ. 2017. Т. 25. N 9. С. 556 - 562

28. Gelfand A.A. Pediatric and Adolescent Headache. Continuum (Minneap Minn). 2018; 24(4): 1108 - 1136. doi: 10.1212/CON.0000000000000638

29. Steiner T.J., Jensen R., Katsarava Z., Linde M., MacGregor E.A., Osipova V., et al. Aids to management of headache disorders in primary care (2nd edition) on behalf of the European Headache Federation and lifting the burden: the global campaign against headache. J. Headache Pain. 2019; 20(1): 57. https://doi.org/10.1186/s10194-018-0899-2

30. Mack KJ, Gladstein J. Management of chronic daily headache in children and adolescents. Paediatr Drugs. 2008; 10(1): 23 - 9. doi: 10.2165/00148581-200810010-00003. PMID: 18162005.

31. Klein J., Koch T. Headache in Children. Pediatrics in Review 2020; 41(4): 159 - 171 doi: 10.1542/pir.2017-0012

32. Hamalainen M.L. Ibuprofen or acetaminophen for the acute treatment of migraine in children: a double-blind, randomized, placebo-controlled, crossover study/M.L. Hamalainen, K. Hoppu, E. Valkeila [et al.]//Neurology. - 1997. - Vol. 48. - P. 102 - 107.

33. Lewis, D.W. Children's ibuprofen suspension for pediatric migraine/D.W. Lewis, B.Kellstein, G. Dahl [et al.]//Ann. Neurol. - 2001. - Vol. 50(3), Suppl. 1. - P. 93.

34. Hamalainen, M.L. Sumatriptan for migraine attacks in children: a randomized placebo-controlled study. Do children with migraine respond to oral sumatriptan differently than adults?/M.L. Hamalainen, K. Hoppu, P. Santavuori//Neurology. - 1997. - Vol. 48. - P. 1100 - 1103.

35. Smith, T.R. Sumatriptan and naproxen sodium for the acute treatment of migraine/T.R. Smith, A. Sunshine, S.R. Stark [et al.]//Headache. - 2005. - Vol. 45 (8). - P. 983 - 991.

36. Ahonen, K. A randomized trial of rizatriptan in migraine attacks in children/K. Ahonen, M. L. Hdmdldinen, M. Eerola, K. Hoppu//Neurology. - 2006. - Vol. 67(7). - P. 1135 - 40.

37. Linder, S.L. Zolmitriptan provides effective migraine relief in adolescents/S.L. Linder, A.J. Dowson//Int. J. Clin. Pract. - 2000. - Vol. 54. - P. 466 - 469.

38. Ueberall, M.A. Intranasal sumatriptan for the acute treatment of migraine in children/M.A. Ueberall//Neurology. - 1999. - Vol. 52. - P. 1507 - 1510.

39. Winner, P. Rizatriptan Adolescent Study Group. Rizatriptan 5 mg for the acute treatment of migraine in adolescents: a randomized, double-blind, placebo-controlled study/P. Winner, D. Lewis, W.H. Visser [et al.]//Headache. - 2002. - Vol. 42 (1). - P. 49 - 55.

40. Lewis, D.W. Practice parameter: pharmacological treatment of migraine headache in children and adolescents: report of the American Academy of Neurology Quality Standards Subcommittee and the Practice Committee of the Child Neurology Society/D.W. Lewis, S. Ashwal, A. Hershey [et al.]//Neurology. - 2004. - Vol. 63 (12). - P. 2215 - 2224.

41. Нестеровский, Ю.Е. Принципы лечения головных болей у детей и подростков/Ю.Е. Нестеровский, Н.Н. Заваденко//Фарматека. - 2013. - N 1. - С. 106 - 111.

42. Kabbouche, M.A. Tolerability and effectiveness of prochlorperazine for intractable migraine in children/M.A. Kabbouche, A.L. Vockell, S.L. LeCates [et al.]//Pediatrics. - 2001. - Vol. 107 (4). - P. 62.

43. Oskoui M, Pringsheim T, Holler-Managan Y, et al. Practice guideline update summary: Acute treatment of migraine in children and adolescents: Report of the Guideline Development, Dissemination, and Implementation Subcommittee of the American Academy of Neurology and the American Headache Society. Neurology. 2019 Sep 10; 93(11): 487 - 499.

44. Нестеровский Ю.Е., Заваденко Н.Н., Шипилова Е.М. Первичные головные боли у детей: диагностика и принципы лечения. Consilium Medicum. 2019; 21(9): 74 - 80. doi: 10.26442/20751753.2019.9.190464

45. Baumann, R.J. Behavioral treatment of migraine in children and adolescents/R.J. Baumann//Paediatr. Drugs. - 2002. - N 4(9). - P. 555 - 561.

46. Blume HK, Brockman LN, Breuner CC. Biofeedback therapy for pediatric headache: factors associated with response. Headache. 2012; 52(9): 1377 - 1386. doi: 10.1111/j.1526-4610.2012.02215.x.

47. Powers, S.W., Andrasik F. Biobehavioral treatment, disability, and psychological effects of pediatric headache. Pediatr. Arm. 2005; 34(6): 461 - 465.

48. Lewis, D.W. Randomized, double-blind, placebo-controlled study to evaluate the efficacy and safety of topiramate for migraine prevention in pediatric subjects 12 to 17 years of age/D.W. Lewis, P. Winner, J. Saper [et al.]//Pediatrics. - 2009. - Vol. 123 (3). - P. 924 - 34.

49. Winner, P. Topiramate Pediatric Migraine Study Investigators. Topiramate for migraine prevention in children: a randomized, double-blind, placebo-controlled trial/P. Winner, E.M. Pearlman, S.L. Linder [et al.]//Headache. - 2005. - Vol. 45 (10). - P. 1304 - 12.

50. Lakshmi, C.V. Topiramate in the prophylaxis of pediatric migraine: a double-blind placebo-controlled trial/C.V. Lakshmi, P. Singhi, P. Malhi, M. Ray//J. Child. Neurol. - 2007. - Vol. 22 (7). - P. 829 - 35.

51. Oskoui M, Pringsheim T, Billinghurst L, et al. Practice guideline update summary: pharmacologic treatment for pediatric migraine prevention: report of the Guideline Development, Dissemination, and Implementation Subcommittee of the American Academy of Neurology and the American Headache Society. Neurology 2019; 93: 500 - 509.

52. Caruso, J.M. The efficacy of divalproex sodium in the prophylactic treatment of children with migraine/J.M. Caruso, W.D. Brown, G. Exil, G.G. Gascon//Headache. - 2000. - Vol. 40. - P. 672 - 676.

53. Serdaroglu, G. Sodium valproate prophylaxis in childhood migraine/G. Serdaroglu, E. Erhan E., H. Tekgul [et al.]//Headache. - 2002. - Vol. 42. - P. 819 - 822.

54. Bidabadi, E. A randomized trial of propranolol versus sodium valproate for the prophylaxis of migraine in pediatric patients/E. Bidabadi, M. Mashouf//Paediatr. Drugs. - 2010. - N 12(4). - P. 269 - 75.

55. Nalp, A. Comparison of the effectiveness of topiramate and sodium valproate in pediatric migraine/A. Nnalp, N. Uran, A. - J. Child. Neurol. - 2008. - Vol. 23 (12). - P. 1377 - 81.

56. Hikita, T. Effective prophylactic therapy for cyclic vomiting syndrome in children using valproate/T. Hikita, H. Kodama, N. Nakamoto [et al.]//Brain. Dev. - 2009. - Vol. 31(6). - P. 411 - 3.

57. Forsythe, W.I. Propranolol (Inderal) in the treatment of childhood migraine/W.I. Forsythe, D. Gillies, M.A. Sills//Dev. Med. Child. Neurol. - 1984. - Vol. 26. - P. 737 - 741.

58. Ludvigsson, J. Propranolol used in prophylaxis of migraine in children/J. Ludvigsson//Acta Neurol. - 1974. - Vol. 50. - P. 109 - 115.

59. Hershey, A.D. Effectiveness of amitriptyline in the prophylactic management of childhood headaches/A.D. Hershey, S.W. Powers, A.L. Bentti, T.J. deGrauw//Headache. - 2000. - Vol. 40. - P. 539 - 549.

60. Guidetti, V. Flunarizine and migraine in childhood: an evaluation of endocrine function/V. Guidetti, B. Moscato, S. Ottaviano [et al.]//Cephalalgia. - 1987. - N 7. - P. 263 - 266.

61. Sorge, F. Flunarizine in prophylaxis of childhood migraine. A double-blind, placebo-controlled crossover study/F. Sorge, R. DeSimone, E. Marano [et al.]//Cephalalgia. - 1988. - N 8. - P. 1 - 6.

62. Lewis, D.W. Prophylactic treatment of pediatric migraine/D.W. Lewis, S. Diamond, D. Scott [et al.]//Headache. - 2004. - Vol. 44. - P. 230 - 237.

63. Ashrafi MR, Salehi S, Malamiri RA, et al. Efficacy and safety of cinnarizine in the prophylaxis of migraine in children: a double-blind placebo-controlled randomized trial. Pediatr Neurol 2014; 51: 503 - 508.

64. Gillies, D. Pizotifen (Sanomigran) in childhood migraine. A double-blind controlled trial/D. Gillies, M. Sills, W.I. Forsythe//Eur. Neurol. - 1986. - Vol. 25 (1). - P. 32 - 5.

65. Symon, D.N. Double blind placebo controlled trial of pizotifen syrup in the treatment of abdominal migraine/D.N. Symon, G. Russell//Arch. Dis. Child. - 1995. - Vol. 72 (1). - P. 48 - 50.

66. Schoenen, J. Effectiveness of high-dose riboflavin in migraine prophylaxis. A randomized controlled trial/J. Schoenen, J. Jacquy, M. Lenaerts//Neurology. - 1998. - Vol. 50 (2). - P. 466 - 470.

67. , P.S. Efficacy of coenzyme Q10 in migraine prophylaxis: a randomized controlled trial/P.S. , L. Di Clemente, G. Coppola [et al.]//Neurology. - 2005. - Vol. 64 (4). - P. 713 - 715.

68. Pfaffenrath, V. Magnesium in the prophylaxis of migraine-a--double-blind placebo-controlled study/V. Pfaffenrath, P. Wessely, C. Meyer [et al.]//Cephalalgia. - 1996. - Vol. 16 (6). - P. 436 - 440.

69. Lipton, R.B. Petasiteshybridus root (butterbur) is an effective preventive treatment for migraine/R.B. Lipton, H. H, K.M. [et al.]//Neurology. - 2004. - Vol. 63 (12). - P. 2240 - 2244.

70. Pothmann, R. Migraine prevention in children and adolescents: results of an open study with a special butterbur root extract/R. Pothmann, U. Danesch//Headache. - 2005. - Vol. 45 (3). - P. 196 - 203.

71. Powers SW, Kashikar-Zuck SM, Allen JR, et al. Cognitive behavioral therapy plus amitriptyline for chronic migraine in children and adolescents: a randomized clinical trial. JAMA 2013; 310: 2622 - 2630.

72. Hunfeld J.A.M., Passchier J. Боль и оценка степени боли у детей. РМЖ. 1997; 7: 2.

73. Lewis DW, Ashwal S, Dahl G, Dorbad D, Hirtz D, Prensky A, Jarjour I; Quality Standards Subcommittee of the American Academy of Neurology; Practice Committee of the Child Neurology Society. Practice parameter: evaluation of children and adolescents with recurrent headaches: report of the Quality Standards Subcommittee of the American Academy of Neurology and the Practice Committee of the Child Neurology Society. Neurology. 2002 Aug 27; 59(4): 490 - 8. doi: 10.1212/wnl.59.4.490. PMID: 12196640.

74. Evers S, Rahmann A, Kraemer C, et al. Treatment of childhood migraine attacks with oral zolmitriptan and ibuprofen. Neurology. 2006; 67(3): 497 - 499. doi: 10.1212/01.wnl.0000231138.18629.d5

75. Ho TW, Pearlman E, Lewis D, et al. Efficacy and tolerability of rizatriptan in pediatric migraineurs: results from a randomized, double-blind, placebo-controlled trial using a novel adaptive enrichment design. Cephalalgia. 2012; 32(10): 750 - 765. doi: 10.1177/0333102412451358

76. Rastogi, R.G., Borrero-Mejias, C., Hickman, C., Lewis, K.S., & Little, R. (2018). Management of Episodic Migraine in Children and Adolescents: a Practical Approach. Current Neurology and Neuroscience Reports, 18(12). doi: 10.1007/s11910-018-0900-0

77. Fayyazi A, Pezeshki N, Mansuri H, Khajeh A. Comparing Prophylactic Effect of Levetiracetam, Sodium Valproate, and Propranolol in Pediatric Migraine: A Randomized Clinical Trial. Iran J Child Neurol. 2023 Fall; 17(4): 105 - 115. doi: 10.22037/ijcn.v17i1.21330.

78. Rao R, Hershey AD. An update on acute and preventive treatments for migraine in children and adolescents. Expert Rev Neurother. 2020 Oct; 20(10): 1017 - 1027. doi: 10.1080/14737175.2020.1797493. Epub 2020 Jul 28. PMID: 32700569.

79. Gelfand AA. Pediatric and Adolescent Headache. Continuum (Minneap Minn). 2018 Aug; 24(4, Headache): 1108 - 1136. doi: 10.1212/CON.0000000000000638. PMID: 30074552.

80. Al-Futaisi A. Pediatric Migraines: A Comprehensive Review and Perspectives on Diagnosis and Treatment. Oman Medical Journal. 2023 May 31; 38(3): e499. e499. doi: 10.5001/omj.2023.45

81. Рачин А.П., Корсунская Л.Л., Завадская М.А., Голубова Т.Ф., Гармаш О.И., Завадский А.В., and Писаная Л.А.. "Коррекция цефалгического синдрома у пациентов детского возраста на этапе санаторного лечения: простое рандомизированное проспективное исследование" Вестник восстановительной медицины, vol. 21, no. 6, 2022, pp. 110 - 118.